Maximizing Patient Goal Attainment

Knee Osteoarthritis Clinical Trial

— mGAME  

Official title:

Maximizing Patient Goal Attainment, Motivations and Expectations (mGAME) in Elective Musculoskeletal Care

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05652270
• Other study ID #: STUDY02001760
• Status: Recruiting
• Phase: N/A
• Start date: April 21, 2023
• Est. completion date: September 30, 2025

Study information

• Verified date: November 2023
• Source: Dartmouth-Hitchcock Medical Center
• Contact: Jiaoyuan Elisabeth Diallo
• Phone: 603-653-9496
• Email: jiaoyuan.elisabeth.diallo[@]hitchcock.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 260
• Est. completion date: September 30, 2025
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Individuals 21 years of age or older

• New patients or existing patients with a new problem that are scheduled to see an orthopaedic surgeon in the Hip and Knee Arthroplasty service for a knee consult.

Exclusion Criteria:

• Individuals who are unable to consent or complete surveys without assistance

• Non-English speaking

• Patients who are less than 12 months from surgery on the knee they are being evaluated for, less than 6 months from surgery on the spine, or less than 3 months from another knee/hip surgery

Related Conditions & MeSH terms

• Knee Injuries
• Knee Injuries and Disorders
• Knee Osteoarthritis
• Knee Pain Chronic
• Wounds and Injuries

Intervention

Behavioral:
• Goal Attainment
Development of an attainable goal
• Goal Development
A Systematic process to help patients create "SMaRT " goals
• Goal Tracking
Setting milestones to allow patients to track their progress towards their developed goal

Locations

Country	Name	City	State
United States	Dartmouth Hitchcock Medical Center	Lebanon	New Hampshire

Sponsors (2)

Lead Sponsor	Collaborator
Dartmouth-Hitchcock Medical Center	Medacta USA

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To evaluate the effectiveness of the goal development intervention using the Goal Attainment Outcome Measure	To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.	8 Months
Secondary	To assess the intervention's ability to improve shared decision making using the collaboRATE measure	To assess the acceptability, usability, as well as qualitatively the appropriateness, feasibility, and scalability of integrating the brief patient goal development intervention into standard clinical care. To assess the intervention's ability to improve shared decision making.	8 Months